Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-05 Purchase |
2023-06-05 9:52 pm |
ImmunityBio Inc. | IBRX | BLASZYK MICHAEL D Director |
71,915 | $2.7536 | $198,023 | 265,582 (Indirect Direct) |
View |
| 2023-06-02 Purchase |
2023-06-05 7:55 pm |
ImmunityBio Inc. | IBRX | Brennan John Owen Director |
25,000 | $2.828 | $70,700 | 25,000 (Direct) |
View |
| 2023-06-01 Purchase |
2023-06-05 7:54 pm |
ImmunityBio Inc. | IBRX | Clark Wesley Director |
7,000 | $2.91 | $20,370 | 8,000 (Direct) |
View |
| 2021-10-08 Purchase |
2021-10-08 8:31 pm |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
1,930 | $8.8057 | $16,995 | 88,106 (Indirect Direct) |
View |
| 2021-08-20 Sale |
2021-08-24 6:07 pm |
ImmunityBio Inc. | IBRX | Cohen Cheryl Director |
24,777 | $10.07 | $249,603 | 200,617 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-19 8:42 pm |
ImmunityBio Inc. | IBRX | Cohen Cheryl Director |
45,531 | $10.12 | $460,750 | 225,394 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-15 Exercise |
2023-06-16 5:45 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer |
21,030 | $0 | 63,091 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:30 pm |
N/A 2033-06-13 |
ImmunityBio Inc. | IBRX | Selecky Christobel Director |
158,263 | $0 | 158,263 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:29 pm |
N/A 2033-06-13 |
ImmunityBio Inc. | IBRX | MAXWELL LINDA Director |
158,263 | $0 | 158,263 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:28 pm |
N/A 2033-06-13 |
ImmunityBio Inc. | IBRX | Cohen Cheryl Director |
158,263 | $0 | 158,263 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:27 pm |
N/A 2033-06-13 |
ImmunityBio Inc. | IBRX | Clark Wesley Director |
158,263 | $0 | 158,263 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:25 pm |
N/A 2033-06-13 |
ImmunityBio Inc. | IBRX | Brennan John Owen Director |
158,263 | $0 | 158,263 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:24 pm |
N/A 2033-06-13 |
ImmunityBio Inc. | IBRX | BLASZYK MICHAEL D Director |
158,263 | $0 | 158,263 (Direct) |
View |
Ownership(A) |
2023-03-01 8:43 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Clark Wesley Director |
0 | $0 | 1,000 (Direct) |
View |
| 2023-02-05 Exercise |
2023-02-07 6:23 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
83,333 | $0 | 268,916 (Direct) |
View |
| 2023-02-05 Tax Withholding |
2023-02-07 6:23 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
42,192 | $4.33 | 268,916 (Direct) |
View |
| 2022-12-31 Exercise |
2023-01-04 9:49 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
7,598 | $0 | 188,091 (Direct) |
View |
| 2022-12-31 Exercise |
2023-01-04 9:48 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
8,620 | $0 | 299,621 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 9:48 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
4,273 | $5.07 | 299,621 (Direct) |
View |
| 2022-12-12 Conversion |
2022-12-14 4:23 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK Cambridge Equities LP MP 13 Ventures LLC CALIFORNIA CAPITAL EQUITY LLC See remarks 10% Owner |
9,986,920 | $5.67 | 323,244,565 (Indirect) |
View |
| 2022-12-12 Conversion |
2022-12-14 4:23 pm |
2022-08-31 2025-09-30 |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK Cambridge Equities LP MP 13 Ventures LLC CALIFORNIA CAPITAL EQUITY LLC See remarks 10% Owner |
56,625,842 | $0 | 323,244,565 (Indirect) |
View |
| 2022-06-14 Option Award |
2022-06-15 9:26 pm |
N/A 2032-06-14 |
ImmunityBio Inc. | IBRX | Selecky Christobel Director |
167,937 | $0 | 167,937 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-15 9:24 pm |
N/A 2032-06-14 |
ImmunityBio Inc. | IBRX | MAXWELL LINDA Director |
167,937 | $0 | 167,937 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-15 9:22 pm |
N/A 2032-06-14 |
ImmunityBio Inc. | IBRX | Cohen Cheryl Director |
167,937 | $0 | 167,937 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-15 9:20 pm |
N/A 2032-06-14 |
ImmunityBio Inc. | IBRX | Clark Wesley Director |
167,937 | $0 | 167,937 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-15 9:19 pm |
N/A 2032-06-14 |
ImmunityBio Inc. | IBRX | Brennan John Owen Director |
167,937 | $0 | 167,937 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-15 9:16 pm |
N/A 2032-06-14 |
ImmunityBio Inc. | IBRX | BLASZYK MICHAEL D Director |
167,937 | $0 | 167,937 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-25 9:05 pm |
N/A 2032-03-23 |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
10,714 | $0 | 10,714 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-25 9:05 pm |
N/A 2032-03-23 |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-25 9:05 pm |
N/A 2032-03-23 |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK Executive Chairman 10% Owner |
700,000 | $0 | 700,000 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-25 9:04 pm |
N/A 2032-03-23 |
ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer |
14,286 | $0 | 14,286 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-25 9:04 pm |
N/A 2032-03-23 |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
700,000 | $0 | 700,000 (Direct) |
View |
| 2022-02-05 Tax Withholding |
2022-02-08 8:53 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
29,415 | $5.39 | 308,691 (Direct) |
View |
| 2022-02-05 Exercise |
2022-02-08 8:53 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard CEO & President |
83,333 | $0 | 308,691 (Direct) |
View |
| 2021-02-23 Ownership |
2022-01-28 4:29 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Thomas John C Former Director Director |
5,000 | $0 | 216,363 (Direct) |
View |
Ownership |
2022-01-28 4:29 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Thomas John C Former Director Director |
0 | $0 | 216,363 (Indirect) |
View |
| 2021-06-04 Ownership |
2022-01-28 4:28 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Simon Barry J. Director |
71,051 | $0 | 3,031,456 (Direct) |
View |
| 2021-12-15 Option Award |
2021-12-17 5:19 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer |
63,091 | $0 | 63,091 (Direct) |
View |
| 2021-12-09 Exercise |
2021-12-13 4:15 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
17,242 | $0 | 188,091 (Direct) |
View |
| 2021-09-09 Exercise |
2021-09-13 8:34 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer |
7,598 | $0 | 188,091 (Direct) |
View |
| 2021-09-09 Exercise |
2021-09-13 8:32 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard Chief Executive Officer |
8,620 | $0 | 249,976 (Direct) |
View |
| 2021-09-09 Tax Withholding |
2021-09-13 8:32 pm |
N/A N/A |
ImmunityBio Inc. | IBRX | Adcock Richard Chief Executive Officer |
4,273 | $9.95 | 249,976 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:38 pm |
N/A 2031-06-10 |
ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK Executive Chairman 10% Owner |
26,064 | $0 | 26,064 (Direct) |
View |